Publications by authors named "Keiichi Matsubara"

This multicenter prospective study investigated seasonal variation in home blood pressure (HBP) during pregnancy and its association with the frequency of hypertensive disorders of pregnancy (HDP) and developed trimester-specific upper limits of HBP according to season. Low-risk women with singleton pregnancies were recruited at six university hospitals and three maternity clinics. HBP was measured by a sphygmomanometer twice daily and recorded online using a mobile application.

View Article and Find Full Text PDF
Article Synopsis
  • * Researchers used a mouse model to study the effects of the AT2R agonist, compound [C], on PE symptoms, particularly looking at levels of soluble fms-like tyrosine kinase 1 (sFlt-1) and blood pressure.
  • * The findings indicated that compound [C] reduced sFlt-1 and improved hypertension, suggesting it could be a potential treatment for preeclampsia by influencing its pathological mechanisms.
View Article and Find Full Text PDF

Preeclampsia (PE) is a serious complication of pregnancy with a pathogenesis that is not fully understood, though it involves the impaired invasion of extravillous trophoblasts (EVTs) into the decidual layer during implantation. Because the risk of PE is actually decreased by cigarette smoking, we considered the possibility that nicotine, a critical component of tobacco smoke, might protect against PE by modifying the content of exosomes from EVTs. We investigated the effects of nicotine on our PE model mouse and evaluated blood pressure.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to investigate the role of natural killer (NK) cells and regulatory T (Treg) cells in the positive outcomes of high-dose intravenous immunoglobulin (IVIG) treatment for women experiencing recurrent pregnancy losses (RPL) of unclear causes.
  • In a controlled trial involving 50 women receiving IVIG and 49 receiving a placebo, blood samples were analyzed at various points to measure the levels of NK and Treg cells.
  • Results showed that IVIG treatment significantly increased Treg cell percentages and decreased NK cell activity shortly after infusion, suggesting that these changes could contribute to higher rates of live births among participants receiving IVIG.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess the effectiveness of intravenous immunoglobulin (IVIG) therapy for patients with obstetric antiphospholipid syndrome (APS) who did not respond to standard treatments.
  • In the clinical trial, patients received a 5-day course of IVIG alongside their conventional treatments, with the main goal of achieving live births after 30 weeks of pregnancy.
  • Results showed that while IVIG alone did not significantly improve live birth rates, combining it with other therapies led to better pregnancy outcomes for many patients, indicating a need for further research on multi-targeted treatment approaches for obstetric APS.
View Article and Find Full Text PDF

According to the 2004 Japanese definition, early-onset (EO) preeclampsia (PE) is defined as PE occurring at <32 weeks of gestation. This was based on the presence of "dual peaks" (30-31 and 34-35 weeks) in the prevalence of severe forms of hypertension. In contrast, the international definition adopted a cutoff of 34 weeks based on the consensus.

View Article and Find Full Text PDF
Article Synopsis
  • A multicenter study in Japan explored home blood pressure monitoring (HBPM) in pregnant women with a low risk of hypertensive disorders of pregnancy (HDP), involving 218 participants who tracked their blood pressure daily.
  • Results showed that 12 women developed HDP, with systolic and diastolic blood pressure levels rising after 24 weeks of gestation and returning to normal by 4 weeks postpartum.
  • The study concluded that HBPM can help identify HDP early, and established specific blood pressure cut-offs for diagnosing hypertensive conditions at different stages of pregnancy.
View Article and Find Full Text PDF
Article Synopsis
  • Researchers explored the effectiveness of high-dose intravenous immunoglobulin (IVIG) treatment for women experiencing unexplained recurrent pregnancy loss (RPL) in early pregnancy through a double-blind, placebo-controlled trial.
  • The study involved 102 women, with 50 receiving IVIG and 49 receiving a placebo, assessing ongoing pregnancy rates at 22 weeks and live birth rates as primary outcomes.
  • Results showed significantly higher ongoing pregnancy (62.0% vs. 34.7%) and live birth (58.0% vs. 34.7%) rates in the IVIG group, particularly in those treated at 4-5 weeks of gestation, compared to the placebo group.
View Article and Find Full Text PDF

The incidence of chromosomal abnormalities in twin pregnancies is not well-studied. In this retrospective study, we investigated the frequency of chromosomal abnormalities in twin pregnancies and compared the incidence of chromosomal abnormalities in dichorionic diamniotic (DD) and monochorionic diamniotic (MD) twins. We used data from 57 clinical facilities across Japan.

View Article and Find Full Text PDF

Aim: We aimed to evaluate the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of noninvasive prenatal testing (NIPT) in high-risk pregnant women.

Methods: Pregnant women who underwent GeneTech NIPT, the most commonly used NIPT in Japan, between January 2015 and March 2019, at Japan NIPT Consortium medical sites were recruited for this study. The exclusion criteria were as follows: pregnant women with missing survey items, multiple pregnancy/vanishing twins, chromosomal abnormalities in the fetus other than the NIPT target disease, and nonreportable NIPT results.

View Article and Find Full Text PDF

Preeclampsia (PE) is a serious disease that can be fatal for the mother and fetus. The two-stage theory has been proposed as its cause, with the first stage comprising poor placentation associated with the failure of fertilized egg implantation. Successful implantation and placentation require maternal immunotolerance of the fertilized egg as a semi-allograft and appropriate extravillous trophoblast (EVT) invasion of the decidua and myometrium.

View Article and Find Full Text PDF

The pathogenesis of preeclampsia begins when a fertilized egg infiltrates the decidua, resulting in implantation failure (e.g., due to extravillous trophoblast infiltration disturbance and abnormal spiral artery remodeling).

View Article and Find Full Text PDF

Background: Women who receive negative results from non-invasive prenatal genetic testing (NIPT) may find that they later have mixed or ambivalent feelings, for example, feelings of accepting NIPT and regretting undergoing the test. This study aimed to investigate the factors generating ambivalent feelings among women who gave birth after having received negative results from NIPT.

Methods: A questionnaire was sent to women who received a negative NIPT result, and a contents analysis was conducted focusing on ambivalent expressions for those 1562 women who responded the questionnaire.

View Article and Find Full Text PDF

As one of the main antimicrobial peptides, human β-defensin 2 (HBD2) plays multiple roles in the lower genital tract. Based on the Nugent score as a diagnostic criterion for bacterial vaginosis, we sought to clarify the correlations among the Nugent score and interleukin-6 (IL-6) and HBD2 levels in vaginal secretions in association with various types of infection. Ninety-eight women were recruited for this study.

View Article and Find Full Text PDF

Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency is an autosomal recessive mitochondrial fatty acid oxidation disorder that manifests in three clinical forms: (a) severe, (b) milder, and (c) myopathic. Patients with the myopathic form present intermittent muscular symptoms such as myalgia, muscle weakness, and rhabdomyolysis during adolescence or adulthood. Here, the clinical symptoms and serum creatine kinase (CK) levels of a pregnant 31-year-old woman with the myopathic form of VLCAD deficiency were reduced during pregnancy.

View Article and Find Full Text PDF

Objectives: Preeclampsia (PE) is the 2nd leading cause of maternal mortality in developing countries. Maternal deaths caused by PE mainly result from eclampsia. The aim of this study was to survey the current status of PE at a local hospital in Zambia and identify preventive measures against eclampsia.

View Article and Find Full Text PDF

Background: Globally, 2.6 million stillbirths occur every year. Of these, 98% occur in developing countries.

View Article and Find Full Text PDF
Article Synopsis
  • A study was conducted to understand why some noninvasive prenatal tests (NIPT) yield nonreportable results by looking at maternal characteristics and related details.
  • Out of 34,626 pregnant women tested, 110 (0.32%) had nonreportable cfDNA results, primarily due to low fetal fraction or altered genomic profiles.
  • The research highlights the importance of classifying nonreportable results to offer clearer information and lessen anxiety for expecting mothers.
View Article and Find Full Text PDF

Background: A549 carrier cells infected with oncolytic adenovirus can induce complete tumor reduction of subcutaneous ovarian tumors but not intraperitoneal disseminated ovarian tumors. This appears to be a result of the insufficient antitumor effect of A549 carrier cells. Therefore, in the present study, we cloned a novel carrier cell with the aim of improving the antitumor effects.

View Article and Find Full Text PDF

The introduction of laparoscopic surgery has also been beneficial for patients with gynecological malignancies. In this respect, surgeons should receive related training in the context of human resource development. Hands-on training was introduced using Thiel-embalmed human cadavers (THCs) in 2014.

View Article and Find Full Text PDF

To establish the reference values for PAPP-A and total hCG between 11 and 13 weeks of gestation for the use of risk assessment of fetal aneuploidy in Japanese pregnant women. A multicenter prospective study was conducted. The subjects included only Japanese pregnant women with viable singleton who requested the first trimester combined (nuchal translucency and maternal serum marker) screening for fetal aneuploidy.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to evaluate how fetal fractions in non-invasive prenatal testing (NIPT) can help predict pregnancy complications like gestational diabetes and hypertension by comparing results from different gestational ages and maternal characteristics.
  • - Conducted as a multicenter cohort study, it analyzed data from 5,582 women with negative NIPT results to explore the links between fetal fractions and pregnancy outcomes such as miscarriages and complications.
  • - Results indicated that women who developed hypertensive disorders tended to have lower fetal fractions early in pregnancy, but using this marker to predict such conditions proved challenging.
View Article and Find Full Text PDF
Article Synopsis
  • - The study focused on a 3-year nationwide project in Japan to implement non-invasive prenatal testing (NIPT) for detecting aneuploidy in high-risk pregnant women, with proper genetic counseling provided.
  • - Out of 30,613 tests conducted, only 1.81% were positive for aneuploidy, with high true-positive rates for trisomies, and a very low false-negative rate (0.02%).
  • - The research emphasizes the need for a robust genetic counseling system and a supportive welfare framework to assist women who choose to have children with chromosomal conditions.
View Article and Find Full Text PDF

Objective: High-mobility group A1 (HMGA1) protein is known to express in trophoblast; however, the role of migration has not been reported to date. In this study, we investigated the role of HMGA1 on the pathogenesis of preeclampsia using immortalized human trophoblast cell (HTR-8/SVneo).

Materials And Methods: We investigated HMGA1 expression in cytotrophoblasts derived from our preeclampsia model mouse, the CD40L mouse, using immunofluorescence.

View Article and Find Full Text PDF

The purpose of this study is to summarize the results from a survey on awareness of genetic counseling for pregnant women who wish to receive non-invasive prenatal testing (NIPT) in Japan. As a component of a clinical study by the Japan NIPT Consortium, genetic counseling was conducted for women who wished to receive NIPT, and a questionnaire concerning both NIPT and genetic counseling was given twice: once after pre-test counseling and again when test results were reported. The responses of 7292 women were analyzed.

View Article and Find Full Text PDF